Announced
Completed
Financials
Tags
Acquisition
biopharmaceuticals
United States
Biotechnology
Friendly
Majority
Single Bidder
Public
Completed
Synopsis
Danaher, a global science and technology innovator, completed the acquisition of the biopharma business of General Electric, an American multinational conglomerate, for $21bn. “Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable sources to de-risk our balance sheet and continue to solidify our financial position. I am proud of the teams for completing this transaction amidst a great deal of global change," H. Lawrence Culp, GE Chairman and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.